The AI trade changed lanes: out of the giants, into the suppliers. We followed the money.
Yesterday we said MU stays benched until the contract shows up. It showed up — $250 billion of it. Micron moves off the watch bench and into the memory sleeve of the tactical books, joining AVGO and TSM. NVDA, MSFT and GOOGL stay held, not chased — one week of leadership change is information, not a verdict — and CRM stays off the add list. Rotation inside a theme is why we own the sleeve, not one horse: your income plan should never depend on guessing which chip wins.
“Once the shelf is bare, there’s nowhere to turn.” We keep the insurance.
Oil fell 2% to $72.08 on peace signals — and the supply picture got scarier anyway: the SPR at its lowest since 1983, Cushing scraping operational limits, diesel inventories at two-decade lows, gasoline $3.85 vs $2.98 prewar, Gulf exports at half pace through a Navy-escorted corridor. Nigeria’s Dangote refinery, $20 billion and a decade late, hit full capacity just in time and now wants a $50 billion IPO.
Chevron (CVX), Exxon (XOM) and ConocoPhillips (COP) stay reinforced on the down day — thin buffers are exactly what the insurance sleeve insures against, and it pays a dividend while it waits. The pipes (KMI, WMB) keep tolling, the refiners (MPC, VLO) stay benched at 52-week highs, and Dangote’s listing goes on the watch list for the income book’s world tour.
An $80 billion debt pile walks into Hollywood. We’ll wait in the lobby.
Paramount’s (PARA) $81 billion purchase of Warner Bros. Discovery (WBD) closes at 6.5x leverage — MoffettNathanson: “staggering” — with long bonds already at 8.43%. Netflix’s (NFLX) viewing share hit 7.8%, a 14-month low; Fox (FOX) is paying $25 billion for Roku (ROKU); Comcast (CMCSA) is splitting in two. The streaming wars’ bill has arrived.
PARA and WBD stay avoided — we don’t own turnarounds financed at 6.5 times leverage, no matter how famous the logo on the water tower. When a deal’s bonds pay 8.43% while the equity deck promises synergies, the bond market has graded the slideware, and it gave it a C-minus. NFLX stays on watch until engagement stabilizes; if the merger creates value it’ll show up in free cash flow, and we can buy it then — cheaper than the excitement.
An $81 billion purchase closing at 6.5x leverage — MoffettNathanson: “staggering” — with long bonds already at 8.43%. When a deal’s bonds pay 8.43% while the equity deck promises synergies, the bond market has graded the slideware, and it gave it a C-minus.
Boeing’s MAX 7 gets a date — and Boeing gets its signature back.
The FAA is expected to certify Boeing’s (BA) 737 MAX 7 in the latter weeks of July and restore Boeing’s authority to issue final safety sign-offs on its own aircraft. Southwest (LUV), which has waited years for the plane, is the most direct beneficiary — and the transports index rose 2.1% Thursday. The market smells deliveries.
BA moves up the conviction ladder — reinforced in the tactical books on a dated, verifiable catalyst that converts a parked backlog into cash, sized like the turnaround it still is. The defense sleeve around it (LMT, RTX, AVAV) holds; peace trades come and go, and defense budgets have noticed neither. Homebuilders stay off the list while the 30-year sits at 6.49% and June existing-home sales fall to a 4.09 million pace at a record $440,600 median.
The tobacco trade came in from the cold. The income book is checking its coat.
British American Tobacco (BTI) has doubled in two years — a better run, the Journal notes with a straight face, than the Magnificent Seven. Altria (MO) +50%; Philip Morris (PM) at 21x, a 70% premium. New FDA guidance opens the vape-and-pouch lane, and BAT’s U.S. pouch share went 6.7% to 16.2% in a year while institutional exclusions fell from 66% to 60%.
BTI goes under formal evaluation for the income book — the yield, the re-rating runway and the pouch share are real. So are the ethics screens: it’s excluded automatically wherever a client mandate prohibits it, no exceptions. No add today; doubles get evaluated, not chased. MO and PM stay reference points, not positions.
Pepsi beat and fell. Costco grew 10.6% and fell. The gas pump is undefeated.
PepsiCo (PEP) posted higher sales and profit and lost 3.3% anyway — its CEO says gas prices “put additional pressure on the consumer.” Costco (COST) grew June sales 10.6%, down from May’s 13.7%, and fell 4.2%. Seven & i raised guidance because $3.85 gas boosts 7-Eleven. Levi’s (LEVI) recovered 2.2% once everyone re-read the numbers. The consumer isn’t broken; the consumer is doing math.
Holdings unchanged — PEP and COST are watch-list entries, not exits, and the defensive-consumer tilt (DG in the value books) is built for exactly this squeeze. The tell to monitor is whether June’s deceleration becomes a July trend; one soft month buys a note in the file, not a trade.
SpaceX’s bonds had a rough week. The bond market doesn’t do autographs.
SpaceX’s spreads widened a fourth straight day — the $25 billion of 2036 paper sold at 1.4 over Treasurys now trades at 1.7 over, on “fatigue on heavy AI issuance” and too many fast-money holders. Add Paramount’s 8.43% bonds and the day’s binary-risk exhibit — AstraZeneca (AZN) −6.2%, Ionis (IONS) −24% to $64.27 on a failed heart trial — and the pattern holds: equity tells the story, credit tells the odds.
SpaceX stays a watch, now with a credit tripwire: if spreads keep widening while the stock rallies, believe the spreads. AZN and IONS stay avoided — we don’t hold coin flips in retirement money. The boring alternative keeps working: SGOV reinforced at 4%+, zero drama, settles Tuesday.
The Medicare Advantage fight is back — what retirees should actually compare.
A bill would cut MA payments; an op-ed calls it the best program we have; more than half of enrollees choose it. The checklist that actually matters — your doctors, your drugs, your travel, and the switchback window — doesn’t appear in either camp’s ads.
The insurers fighting over the payments stay handled with yesterday’s discipline: UNH held small, CNC and CI still off the list — policy risk in both directions is not a thesis. For clients, this is an October decision made on a July checklist: we do the boring intake — doctors, prescriptions, travel — so open enrollment isn’t a coin flip.
Buc-ee’s is suing a moose.
When your whole friend group turns 70.
The $354 IKEA chair that’s worth $12,000 now.
They sold everything for the Arctic dream. Three years later, they’re selling the dream.
